EDITH JACKSON: Open Payments
NPI 1346588183 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 41 payments from 17 companies in 2025. Trend: 2023 $827 · 2024 $902 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $107 |
| Amgen Inc. | 6 | $99 |
| ABBVIE INC. | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Mannkind Corporation | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| KYOWA KIRIN, INC. | 2 | $36 |
| Eisai Inc. | 2 | $35 |
Products named: Ozempic, REXULTI, OTEZLA, JARDIANCE, TRELEGY ELLIPTA, AFREZZA, LEQVIO, CRYSVITA.
Industry payments across NJ — which companies pay providers there.
